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a  b  s  t  r  a  c  t
The  cDNAs  of two  turkey  cytokines,  interleukin  (IL)-10  and IL-13,  were  cloned  using
oligonucleotide  primers  designed  from  their  chicken  orthologues.  The  coding  regions  of  the
chicken  and  turkey  genes  are  highly  conserved,  with  IL-10  and  IL-13  exhibiting  94.1%  and
90% nucleotide  and 92%  and  79.9%  amino  acid identity  respectively.  Both  showed  consistent
mRNA  expression  in turkey  lymphoid  and  gut  tissues.  Expression  in non-lymphoid  tissues
was  more  variable  but  generally  highest  in the  skin  and  trachea.  Recombinant  turkey  IL-10
was expressed  and  bioactivity  demonstrated  by  inhibition  of  IFN-  synthesis  from  activated
splenocytes.  Chicken  and  turkey  IL-10  cross-reacted  in functional  assays.
© 2012 Elsevier B.V. All rights reserved.
1. Introduction
The immune system of the chicken has been charac-
terised to a far greater extent than that of the turkey,
primarily due to its greater economic status and stim-
ulating more research interest. However, the increasing
consumption of poultry meat other than chicken is driv-
ing a concomitant increase in the economic importance of
other poultry species, including turkeys. There is a sub-
sequent need for improved vaccination strategies, and
therefore a greater understanding of the immune sys-
tems of these species (Kaiser, 2010; Meyerhoff et al.,
2012; Schultz and Magor, 2008). The release of the
chicken genome sequence (International Chicken Genome
Sequencing Consortium, 2004) revolutionised our under-
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standing of the repertoire and biology of immune-related
molecules, including cytokines and chemokines, resulting
in a large and expanding chicken immunological “toolbox”
of reagents (Kaiser et al., 2005; Kaiser, 2007, 2010; Kaiser
and Stäheli, 2008). The availability of genome sequences
for other avian species, including the zebraﬁnch (Warren
et al., 2010), the turkey (Dalloul et al., 2010) and the duck
(http://pre.ensembl.org/Anas platyrhyncos/Info/), should
allow identiﬁcation and subsequent characterisation of
their immune gene repertoires.
Dalloul et al. (2010) catalogued the majority of the
turkey immune gene repertoire, which unsurprisingly
is very similar to that of the chicken. However, only
ﬁve cytokines have been biologically characterised in the
turkey: type I IFN (Suresh et al., 1995), IFN- (Lawson
et al., 2001; Loa et al., 2001), IL-1 (Wu et al., 2007), IL-2
(Lawson et al., 2000), and IL-18 (Kaiser, 2002), and a single
chemokine, IL-8 (also known as CXCLi2) (Wu et al., 2008). A
partial sequence for turkey IL-12 had also been identiﬁed
pre-genome (Balu and Kaiser, 2003). All of these share high
nucleotide (nt) and amino acid (aa) identities with their
chicken orthologues. Only three (IFN-, IL-2 and CXCLi2)
have been tested for cross-reactivity. All three cytokines
0165-2427/$ – see front matter ©  2012 Elsevier B.V. All rights reserved.
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cross-reacted, somewhat surprisingly in the case of IL-2
as chicken and turkey IL-2 share only 69.9% aa identity
(Lawson et al., 2000, 2001; Wu  et al., 2008). This leads to the
hypothesis that other chicken and turkey cytokines would
also show cross-reactivity. In addition, Powell et al. (2009a)
identiﬁed and cloned three turkey T cell surface markers
and demonstrated cross-reactivity of monoclonal antibod-
ies recognising chicken CD8 and CD28 with the respective
turkey orthologues.
To date, reagents have been developed to measure
mRNA expression of turkey cytokines of the induced innate
response (IL-1 and IFN-), an innate pro-inﬂammatory
chemokine, CXCLi2, and cytokines of the T helper (Th)1
adaptive response (IFN-, IL-2, IL-18). The aim of this work
was to clone examples of turkey Th2 cytokines and regula-
tory cytokines, and develop reagents to them.
IL-10 is an anti-inﬂammatory cytokine and is a cru-
cial mediator of immune-regulation following infection
with a range of pathogens, including viruses, bacteria,
fungi, protozoa and helminths in mammals (reviewed by
Couper et al., 2008; Ding et al., 2003). Chicken IL-10 inhibits
IFN- production from mitogen-activated splenocytes, and
increased expression of IL-10 has been linked with sus-
ceptibility to infection with the intracellular protozoan
parasite, Eimeria maxima (Rothwell et al., 2004). IL-10
expression is also signiﬁcantly increased (along with IL-4
and IL-13) in chickens during the lytic phase of infection
with Marek’s disease virus (Heidari et al., 2008), indicat-
ing that IL-10 plays a role in the immuno-regulation of Th1
responses in the chicken.
IL-13 is a Th2 signature cytokine which is criti-
cally involved in protective immunity, being particularly
important in anti-helminthic responses. These effects are
mediated through a variety of mechanisms, including inhi-
bition of inﬂammatory cytokine responses and promoting
IgE class-switching (reviewed by Wynn, 2003). It was
cloned in the chicken through genomic analysis based
on the conservation of synteny with the rest of the Th2
cytokine gene cluster (Avery et al., 2004). We  and oth-
ers have shown that during infection with extracellular
pathogens, chicken IL-13 is induced to far greater levels
than chicken IL-4 (Degen et al., 2005; Powell et al., 2009b;
Schwarz et al., 2011), the canonical Th2 cytokine in man
and mouse. Given that chickens and turkeys are closely
related in evolutionary terms (Dalloul et al., 2010), it seems
likely that IL-10 and IL-13, as well as other immune-related
molecules, will have similar roles in the two species.
2. Materials and methods
2.1. Animals
Turkeys were obtained at hatch from Sun Valley Foods
Ltd. (Ludlow, Shropshire, UK) and maintained at the Insti-
tute for Animal Health (IAH). Turkeys used to produce a
tissue panel were obtained at hatch from British United
Turkeys (Cheshire, UK) and maintained at the University
of Liverpool, Leahurst. Chickens were produced and main-
tained at IAH.
2.2. Cloning and expression of the turkey cDNAs
Turkey splenocytes were isolated, cultured and stimu-
lated with phorbol myristate acetate (PMA) (Sigma, Poole,
UK) as previously described (Lawson et al., 2000). Cells
were harvested 6, 12, 18 and 24 h post-PMA stimulation
and mRNA isolated with an Oligotex Direct Midi kit (Qia-
gen, Crawley, UK).
Primers were designed to chicken IL-10
(Rothwell et al., 2004) and IL-13 (Avery et al.,
2004). For IL-10, nested forward primers (F1: 5′-
TAAAGAATAAAGACCCCAGGATG-3′ (in 5′UTR to the
start codon) and F2: 5′-ATGCAGACCTGCTGCCAAG-
3′ (from the start codon)) and reverse primers in
the 3′UTR (R1: 5′-GCTGAGAGCGGCTGTGC-3′ and
R2: 5′-CTCGTCTGGTGTTTGCAGTT-3′) were used. For
IL-13 a forward primer from the start codon (5′-
ATGCACCGCACACTGAAGGC-3′) and nested reverse
primers (R1: 5′-ATGGGGCCGGGCATCAG-3′ (in 3′UTR) and
R2: 5′-TCAGTTTGCAGCTGTGGC-3′ (from the stop codon))
were used.
First strand synthesis was  carried out for 2 h at 42 ◦C in
a 20 l reaction containing 10 pmol reverse primer, 200 U
Superscript II (Invitrogen, Paisley, UK) and 500 ng template
mRNA. After denaturation of the reverse transcriptase at
94 ◦C for 4 min, 10 l of this template cDNA were added to
a 50 l PCR reaction, containing 20 pmol of each primer,
0.4 mM dNTPs, and 2.5 units of Taq polymerase (Invitro-
gen). Thermal cycling conditions were 30 cycles of 94 ◦C
for 1 min, 50 ◦C for 2 min  and 72 ◦C for 2 min  using a Mas-
tercycler PCR machine (Eppendorf, Cambridge, UK).
PCR products were ligated into pGEM-T Easy (Promega)
and the sequence of representative clones determined
using capillary electrophoresis on a CEQ8000 sequencer
(Beckman Coulter, High Wycombe, UK). Sequence analysis
was  carried out using DSgene and Vector NTI (Invitrogen)
software.
The cDNAs were then subcloned from pGEM-T Easy,
using EcoRI or NotI, into the mammalian expression vector,
pCI-neo (Promega). The resulting clones were transfected
into COS-7 cells using a DEAE-dextran-based method as
previously described (Rothwell et al., 2001, 2004) to pro-
duce high expression of the relevant gene of interest.
The supernatant (containing the relevant recombinant
cytokine) and RNA from the transfected COS-7 cells were
harvested after 2–3 days of culture. RNA was isolated from
the cells with an RNeasy mini kit (Qiagen) for use as a pos-
itive control in real-time qRT-PCR.
2.3. Real-time quantitative RT-PCR
Tissue panels were taken from three turkeys post
mortem. Lymphoid tissues included spleen, bursa of
Fabricius, thymus, caecal tonsil, Harderian gland, Meckel’s
diverticulum and bone marrow. Non-lymphoid tissues
taken were brain, trachea, heart, liver, lung, pancreas,
kidney, ovary, skin and muscle. Tissues from the digestive
tract were also taken, and these were the crop, proven-
triculus, gizzard, upper and lower ileum, caecum and large
intestine. Tissue samples were homogenised separately
using a bead mill (Retsch MM 300, Haan, Germany) and
Author's personal copy
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QIAshredders (Qiagen). RNA was extracted from
homogenates using an RNeasy mini kit (Qiagen) fol-
lowing the manufacturer’s instructions. Eluted RNA was
stored at −70 ◦C prior to use.
Expression of IL-10 and IL-13 in the turkey tis-
sue panel was quantiﬁed using a well-described
method (e.g. Avery et al., 2004; Rothwell et al., 2004;
Eldaghayes et al., 2006). Primers and probes were
designed from the turkey cDNA sequences using the
Primer Express software programme (Applied Biosys-
tems) and were as follows: IL-10 forward primer
5′-CGACCTGGGCAACATGCT-3′; IL-10 reverse primer
5′-CCTCTCGCAGGTGAAGAAGT-3′; IL-10 probe 5′-(FAM)-
CCTGAAGATGACAATGAAGCGCTGTCA-(TAMRA)-3′; IL-13
forward primer 5′-CCTGCACGGCCAGATGA-3′; IL-13
reverse primer 5′-GGCAAGAAGTTCCGCAGGTA-3′;
IL-13 probe 5′-(FAM)-TGCCAGCTGAGCACCGACAACG-
(TAMRA)-3′; IFN- forward primer
5′-AACCTTCCTGATGGCGTGAA-3′; IFN- reverse primer
5′-CTTGCGCTGGATTCTCAAGTC-3′; IFN- probe 5′-(FAM)-
AAAGATATCATGGACCTGGCCAAGCTTCA-(TAMRA)-3′. The
28S and chicken IFN- primer-probe sets were as previ-
ously described (Rothwell et al., 2004). Real-time qRT-PCR
was performed, in triplicate, on RNA from the tissue panels
described above, using the Reverse Transcriptase qPCR
Master Mix  RT-PCR kit (Eurogentec, Southampton, UK),
and ampliﬁcation was performed using the ABI PRISM
7700 Sequence Detection System (Applied Biosciences,
Warrington, UK), with the following cycling conditions:
1 cycle of 50 ◦C for 2 min, 60 ◦C for 30 min  and 95 ◦C for
5 min  followed by 40 cycles of 94 ◦C for 20 s and 59 ◦C for
1 min. Results are expressed as 40-Ct, after normalising
each sample using the Ct value for the 28S rRNA product
for the same sample, as described previously (Avery et al.,
2004; Rothwell et al., 2004; Eldaghayes et al., 2006).
2.4. IL-10 bioassay
The IL-10 bioassay was carried out as previously
described (Rothwell et al., 2004). Brieﬂy, splenocytes from
8-week-old chickens or 3-week-old turkeys were isolated
and resuspended at 5 × 106 cells/ml in DMEM containing
2 mg/ml  BSA, 1% l-glutamine, 1 U/ml penicillin and 1 g/ml
streptomycin. They were added to round-bottomed 96-
well plates or 24-well plates containing serial two-fold
dilutions of recombinant chicken or turkey IL-10 (ex-
COS), in a ﬁnal volume of 200 l/well (96-well plates) or
2 ml/well (24-well plates), in the presence of 12.5 g/ml
PHA (Sigma) or no mitogen. Negative controls included
serial two-fold dilutions of supernatant collected from
COS-7 cells transfected with pCI-neo alone, or media alone,
with or without PHA. Cells were incubated at 41 ◦C, 5% CO2
for 72 h for analysis of IFN- content in the supernatant.
Assays were carried out in triplicate, and repeated three
times.
Supernatants were assayed (in triplicate) for IFN- con-
tent using a quantitative chIFN- capture ELISA (Biosource,
Nivelles, Belgium), as previously described (Lambrecht
et al., 2000), and by bioassay, using the macrophage acti-
vation factor assay, again as previously described (Kaiser
et al., 2000; Lawson et al., 2001). There were insufﬁcient
cells to carry out the bioassay on supernatants from turkey
splenocytes.
Total RNA was isolated from cells in 24-well plates
using the RNeasy mini kit (Qiagen) following the manu-
facturer’s instructions. Puriﬁed RNA was  eluted in 50 l
RNase-free water and stored at −70 ◦C. Real-time qRT-
PCR was used to determine IFN- mRNA expression levels
in PHA-stimulated splenocytes (from chicken and turkey)
treated with recombinant chicken or turkey IL-10 or
mock-transfected COS cell supernatant at various dilu-
tions. Results are expressed as fold-difference from levels
in untreated PHA-stimulated splenocytes.
3. Results and discussion
The turkey Th1 cytokines IFN-, IL-12 and IL-18 have
all been characterised previously (Balu and Kaiser, 2003;
Kaiser, 2007; Lawson et al., 2001) but no reagents have
been available to investigate the turkey Th2 response or
regulatory response.
Turkey IL-10 cDNA was  ampliﬁed from RNA from PMA-
stimulated turkey splenocytes by RT-PCR, using primers
based on the chicken IL-10 cDNA sequence. The coding
sequence of 528 nt from start to stop codon was  identi-
ﬁed and encodes a 175 aa polypeptide (Fig. 1). Sequence
identity between turkey IL-10 and human IL-10 is 61.9%
and 42.5% at the nt and aa levels, respectively. Turkey and
murine IL-10 share 57.6% and 39.1% nt and aa identity,
respectively. Identity between chicken and turkey IL-10
is high, with 94.1% and 92% identity at the nt and aa lev-
els respectively, with complete conservation of the IL-10
family signature motif, G-X-X-K-A-X-X-[DE]-X-D-[ILV]-
[FLY]-[FILMV]-X-X-[ILMV]-[EKQR] (GIYKAMGEFDIFINYIE
for both chicken and turkey, double underlined in Fig. 1).
All cysteine residues in IL-10 are conserved between the
chicken and turkey and all hydrophobic aa of the heptad
repeats are conserved, suggesting that turkey IL-10 has
six -helices, as do chicken and mammalian IL-10. The
cDNA sequence was submitted to Ensembl with the Acc.
No. AM493432.
IL-10 mRNA expression (Fig. 2A) was  consistent in all
lymphoid tissues with lowest expression in bone marrow.
Expression in non-lymphoid tissues was variable with rel-
atively high expression in brain, lung and ovary, followed
by the heart and liver. The proﬁle of IL-10 mRNA expres-
sion in digestive tissues was fairly consistent, presumably
as this is an antigenic environment and a potential site of
pathogen entry. No expression was seen in the proventricu-
lus and there was lower expression in the gizzard relative
to other digestive tissues. Little or no IL-10 mRNA expres-
sion was seen in the remaining tissues. When comparing
IL-10 mRNA expression in the chicken and turkey, differen-
tial expression was seen in chicken lymphoid tissues while
IL-10 mRNA was constitutively expressed in turkey lym-
phoid tissues. IL-10 mRNA expression was  not detected in
the kidney or muscle of either species but was  detected in
the liver and lung of both (Rothwell et al., 2004).
We assessed the ability of recombinant chicken and
turkey IL-10 (ex-COS) to inhibit IFN- expression by
chicken and turkey splenocytes following PHA-stimulation
Author's personal copy
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 helix A 
human   MHSSALLCCLVLLTGVRASPGQGTQS ENSC THFPGNLPNMLR DLRDA FSRVK TFFQ MKD-   59 
murine  MPGSALLCCLLLLTGMRISRGQYSREDNN CTHFPVGQSHM LLELRTA FSQV KTFFQTK D-   59 
chicken     MQTCCQALLLLLAACTLPAHCL EPTC LHFSELLPARLRELRVK FEEI KDYFQSR DD   56 
turkey   MQTCCQALLPLLAACTLPAHCL EPTC LHFSELLPIQLRELRVK FEEI KDYFQSR DD   56
**  *     *  *  
 helix B       helix C     helix D 
human QLDNLLLKESLLEDFKGYLGCQ ALSEM IQFYLEEVMP QAENQDPDIKAH VNSLGEN LKT L 119 
murine QLDNILLTDSLMQDFKGYLGCQ ALSEM IQFYLVEVMP QAEKHGPEIK EHLNSLGEK LKT L 119 
chicken ELNIQLLSSELLDEFKGTFGCQ SVSEM LRFYTDEVLP RAMQTSTSHQ QSMGDLGNM LLG L 116 
turkey ELNIQLLNSELLDEFKGNFGCQ SVSEM LRFYTDEVLP RAMKTSTSHQ ESMGDLGNM LLG L 116  
  * 
 helix E  helix F  
human RLRLRRCHRFLPCE NKSKAV EQV KNA FNKL QEKGIYKA MSEFDIFINYIE AYM TMK IRN  178 
murine RMRLRRCHRFLPCE NKSKAV EQV KSD FNKLQDQGVYKA MNEFDIFIN CIE AYMMIK MKS  178 
chicken KATMRRCHRFFTCE KRSKAI KQI KET FEKM DENGIYKA MGEFDIFINYIE EYLLMR RRK  175 
turkey KMTMKRC HHFFTCE RRSK VIKQI KET FEKM DENGIYKA MGEFDIFINYIE EYLLMKRGK  175   
* * 
Fig. 1. Comparison of the predicted aa sequences of human (hu), murine (mu), chicken (ch) and turkey (tu) IL-10. Shaded areas represent conservation of
aa  similarity – the darker the shading, the more conserved the residue across species. Dashes indicate gaps in the alignment. Conserved cysteine residues in
the  avian predicted proteins are indicated with an asterisk. The -helical assignments are based on the structure of human IL-10, as indicated by overlying
lines  (Zdanov et al., 1996). The predicted signal peptide cleavage site is indicated by an arrow. Double underlined bases indicate the IL-10 family signature
motif.  Acc. Nos. of the cDNA sequences are: human, NM 000572; murine, NM 010548; chicken, AJ621254; turkey, AM493432.
at the mRNA (real-time qRT-PCR, Fig. 3A and B) and protein
levels (ELISA, Fig. 3C and D and bioassay, Fig. 3E).
At the mRNA level (24 h post-stimulation), both
chicken and turkey IL-10 inhibited IFN- expression by
chicken splenocytes after stimulation with PHA in a dose-
dependent manner (Fig. 3 A). Similarly, there was  inhibition
of IFN- production from PHA-stimulated turkey spleno-
cytes by recombinant chicken and turkey IL-10, although
20
A IL-10
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12
8
4
40-Ct
0
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IL-13
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8
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Fig. 2. Expression patterns of (A) IL-10 and (B) IL-13 mRNA, as measured
by real-time quantitative RT-PCR, in lymphoid tissues, non-lymphoid tis-
sues and digestive tissues of the turkey. The average expression in tissues
from each of three birds is shown, with results expressed as mean 40-Ct
values ± SEM. 1, spleen; 2, bursa of Fabricius; 3, thymus; 4, caecal tonsil;
5, Harderian gland; 6, Meckel’s diverticulum; 7, bone marrow; 8, brain; 9,
trachea; 10, heart; 11, lung; 12, liver; 13, pancreas; 14, kidney; 15, ovary;
16, skin; 17, muscle; 18, crop; 19, proventriculus; 20, gizzard; 21, upper
ileum; 22, lower ileum; 23, caecum; 24, large intestine.
the effect was  less marked than that observed on chicken
cells. This effect had titrated out by 1:1000 dilution of the
recombinant protein.
At the protein level (72 h post-stimulation), recombi-
nant chicken and turkey IL-10 inhibited the production of
IFN- by both chicken and turkey splenocytes at high con-
centrations, as measured by ELISA, and this effect titrated
out with increasing dilution of recombinant IL-10 (Fig. 3C
and D respectively).
The bioassay measures the ability of IFNs, includ-
ing IFN-, to stimulate nitric oxide (NO) production by
a chicken macrophage cell line (HD11). Both recombi-
nant chicken and turkey IL-10 inhibited production of
NO-inducing agents (presumably IFN-) following stim-
ulation of splenocytes with PHA, the inhibition titrating
out with increasing dilution of recombinant IL-10 (Fig. 3E).
IFN- production by PHA-stimulated splenocytes was  not
inhibited by the presence of supernatant from COS cells
transfected with pCI-neo alone.
Our attempts to clone and sequence turkey IL-4 failed
(data not shown), but turkey IL-13 cDNA was ampliﬁed
from turkey RNA by RT-PCR using primers designed to
chicken IL-13. The coding sequence of 420 nt from start
to stop codon was identiﬁed (Fig. 4), which included the
insertion of an additional serine residue, at position 27
(CCA at 80–82 bp), compared to the chicken sequence.
Sequence identity between turkey IL-13 and human IL-13
is 49.6% and 15.0% at the nt and aa levels, respectively,
with similar levels of identity between turkey and murine
IL-13. Mammalian and avian IL-13 each has ﬁve cysteine
residues, four of which are conserved in location. Iden-
tity between chicken and turkey IL-13 is high, with 90.0%
and 79.9% identity at the nt and aa levels, respectively.
Amino acid changes show evidence of some clustering,
with seven aa changes from positions 24 to 31, which is
the region directly following the predicted cleavage site for
processing of the signal peptide of mammalian IL-13. Five
aa changes occur between positions 39 and 47 which lie
Author's personal copy
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Fig. 3. Effect of recombinant chicken and turkey IL-10 on the ability of chicken (A, C and E) and turkey (B and D) splenocytes to express IFN- following
PHA  stimulation. Splenocytes were stimulated with PHA and co-cultured with different dilutions of recombinant chicken or turkey IL-10 (ex-COS), or
supernatant from COS cells transfected with the expression vector alone (pCI-neo). IFN- mRNA expression by chicken (A) or turkey (B) splenocytes at 24 h,
as  measured by real-time quantitative RT-PCR. Data are expressed as fold change compared to appropriate splenocytes cultured with PHA alone. IFN-
protein expression in chicken (C) and turkey (D) splenocytes (OD450) at 72 h, as measured by capture ELISA. Serial two-fold dilutions start from a 1:4 dilution
for  the chicken splenocytes and a 1:10 dilution for the turkey splenocytes. (E) NO-inducing activity (presumed to be IFN-) (OD543) in chicken splenocytes
at  72 h, as measured by the macrophage activation factor assay. Serial two-fold dilutions start from a 1:4 dilution. Data shown are representative of three
separate experiments for each species.
within helix A of human IL-13 and four changes between
positions 80 and 84, three of which lie within helix B of
human IL-13. Five aa changes between positions 102 and
107 lie between helix C and the second -sheet (Avery et al.,
2004). Since the exon boundaries are consistent between
species (http://www.ensembl.org/Meleagris gallopavo/),
this shows that a high proportion of replacements occurs in
exons 1, 3 and 4. All of the cysteine residues in IL-13 are con-
served between the chicken and turkey. With the relatively
high level of aa identity and the conservation of cysteine
residues, we could speculate that the biological activi-
ties exhibited by chicken IL-13 are conserved between the
two avian species, and that turkey and chicken IL-13 will
cross-react. The sequence was submitted to Ensembl with
the Acc. No. AM493431.
Expression levels of IL-13 mRNA (Fig. 2B) were gen-
erally lower than those of IL-10 in the panel of tissues
analysed. IL-13 mRNA was detected in all lymphoid organs
but to the highest degree in the thymus. The highest expres-
sion of IL-13 in non-lymphoid tissues was seen in the
trachea, followed by ovary, skin and muscle. IL-13 mRNA
was also expressed in all digestive tract tissues to simi-
larly low levels and to varying extents in the non-lymphoid
tissues. Interestingly, expression of IL-13 in the chicken,
compared to the turkey, seems more restricted (Avery et al.,
2004), particularly in the non-lymphoid tissues, where
Author's personal copy
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helix A 
human   MHPLLNPLLLALGLMALL LTTVIAL TCLGGFASPGPVP PST----A LRE LIEELVN ITQN  56 
murine MALW VTAVLAL ACLGG LAAPGPVP RSVSLP LTLKE LIEELSN ITQD  46 
chicken   MHRT LKAALAL LCLAE LVASTPL AMN-LSK LKLSD ITQGIQK LNRG  45 
turkey MHRT LKAALAL LCLAE LIASTPLP TSSMPK MKLSD ITRS IQQ LNKG  46 
* 
1     helix B   helix C 
human QKAPLCN GSMVWS INLTAG------ MYCAALES LINVS GCS----A IEK TQRMLSGFCPH 106 
murine Q-TPLCN GSMVWS VDLAAG------GF CVALDS LTNIS NCN----A IYR TQRILHGLCNR  95 
chicken V-QVPCNDTRVAQ VAFKDRKLSEQE LLCQAATV LDNMT DCKKDYEP LIT SLKSLHGMTNC 104 
turkey E-QVPCN DTRVAQ VAFTDRKLSEQE LLCQAATV LTKVT RCKKDYEP LIT SLQSLHGQMSC 105 
   * *    *   *
2   helix D 
human   KVSAGQFSSLHVR DTK IEVAQFVKD LLLHLK KLFREGQFN    146 
murine  KAPT-TVSSLP-- DTK IEVAHFITK LLSYTKQLFRHGPF     131 
chicken PPST---------DNE IYLRNFLPA LGNYTQALYRRISATAAN 138 
turkey  QLST---------DNE IYLRNFLPT LGNFTQALYRRNTATAAN 139 
Fig. 4. Comparison of the predicted aa sequences of human (hu), murine (mu), chicken (ch) and turkey (tu) IL-13. Shaded areas represent conservation of
aa  similarity – the darker the shading, the more conserved the residue across species. Dashes indicate gaps in the alignment. Conserved cysteine residues in
the  avian predicted proteins are indicated with an asterisk. The -helical and -sheet assignments are based on the structure of human IL-13 and indicated
by  overlying lines (Bamborough et al., 1994). The predicted signal peptide cleavage site is indicated by an arrow. Acc. Nos. of the cDNA sequences are:
human,  NM 002188; murine, NM 008355; chicken, NM 001007085; turkey, AM493431.
expression of chicken IL-13 was restricted to the lung and
brain.
The turkey cytokines described herein, and the reagents
developed to them, make it possible to extend the char-
acterisation of the turkey’s immune response. We  now
have the means to measure key cytokines involved in the
innate immune response, a Th1 or Th2-type response, as
well as a regulatory T cell response. In addition to the
immune response of turkeys to foot pad dermatitis (Mayne
et al., 2007) and histomonosis (Powell et al., 2009b), it
would be interesting to investigate the immune response
to other commercially important turkey pathogens, includ-
ing turkey rhinotracheitis, an avian pneumovirus which
causes up to 30% mortality (10–100% morbidity), avian ﬂu,
coccidia and bacteria (including Salmonella,  Campylobacter
and Escherichia coli). Also of interest are re-emerging turkey
diseases, such as Bluecomb disease, caused by a turkey
coronavirus, and Poult enteritis mortality syndrome, an
emerging disease whose etiology remains unclear. The
reagents developed during this study will aid these efforts.
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